Microbiology · MU Sofia

67. Non-fermentative Gram-negative bacteria: genera Acinetobacter, Stenotrophomonas & Burkhold

Covers three non-fermentative Gram-negative genera, Acinetobacter, Stenotrophomonas and Burkholderia, starting with a comparison table of their Gram stain, shape, motility, oxidase, habitat and special traits. It then goes through each organism's epidemiology, the infections it causes, laboratory diagnosis and treatment, with Burkholderia pseudomallei and B. cepacia treated separately. Two further comparison tables set out lab tests and a summary of first-line drugs with resistance concerns.

Inside: 7 sections · 7 labelled pictures · 4 tables · 15 flashcards · 3 min

Topic 67 of 113 in the MU Sofia syllabus for Microbiology (Dental Medicine, Year 2). The free AceMed note covers it in 7 sections, about 229 words (3 min of reading), with 15 flashcards.

In this note

  1. Non-fermentative Gram-negative bacteria: Genera Acinetobacter, Stenotrophomonas & Burkholderia
  2. General Features
  3. Acinetobacter baumannii
  4. Stenotrophomonas maltophilia
  5. Burkholderia
  6. Lab Diagnosis
  7. Summary of Treatments

Acinetobacter baumannii

Epidemiology & Transmission:

  • Ubiquitous: hospital surfaces, soil, water, even dry environments.
  • Transmitted via hospital equipment, hands of healthcare workers, and invasive devices (catheters, ventilators).

Diseases:

  • Nosocomial pneumonia (esp. ventilator-associated)
  • UTIs
  • Wound infections (trauma/burn)
  • Sepsis and meningitis (rare but severe)

Diagnosis:

  • Gram stain: short, plump G(–) coccobacilli in pairs.
  • Culture: grows on blood and MacConkey agar.
  • Biochem: oxidase variable, non-fermentative.

Treatment:

  • Highly multidrug resistant; often susceptible only to colistin or tigecycline.
  • Carbapenem-resistant A. baumannii (CRAB) is a critical concern.

Stenotrophomonas maltophilia

Epidemiology:

  • Common in moist hospital areas (catheters, disinfectants).
  • Seen in immunocompromised patients on broad-spectrum antibiotics.

Virulence:

  • Not very aggressive → primary virulence is extreme antibiotic resistance.

Diseases:

  • Bacteremia, especially via contaminated IV lines
  • Pneumonia, especially in ventilated or neutropenic patients

Diagnosis:

  • Gram-negative rods, oxidase (–), slow growth on nutrient media.
  • Often grows on MacConkey but non-lactose fermenter.

Treatment:

  • Trimethoprim-sulfamethoxazole (TMP-SMX) is drug of choice.
  • Resistant to carbapenems and often to aminoglycosides.

Burkholderia

B. pseudomallei (agent of melioidosis)

  • Endemic in Southeast Asia and Northern Australia.
  • Found in wet soil; transmission via cuts, inhalation, or ingestion.
  • Pathogenesis: survives inside macrophages, leads to abscess formation and sepsis.

Diseases:

  • Pneumonia (necrotizing), abscesses, septicemia.
  • Often mimics tuberculosis.

Treatment:

  • Ceftazidime or meropenem, followed by prolonged oral TMP-SMX.

B. cepacia

  • Low virulence but dangerous in CF (cystic fibrosis) patients and immunocompromised.
  • Can cause UTIs, pneumonia, catheter-related infections.

Treatment:

  • Trimethoprim-sulfamethoxazole, some sensitivity to fluoroquinolones.
  • Resistant to many β-lactams and aminoglycosides.

Continue reading free

The whole note, all 7 sections, is free with an AceMed account, with its 15 flashcards. Premium adds flashcard recall, highlights and Ask AI.